malaria_record: 92

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
92 92 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 21b9769b2f14191b9c895bb9f18093af3d5918cb818c81baff2ee4402928c016
  • All areas in the states of Acre, Amapá, Amazonas, Rondônia, and Roraima
  • Present in the states of Maranhão, Mato Grosso, and Pará, but rare cases in their capital cities (São Luis [capital of Maranhão], Cuiabá [capital of Mato Grosso], Belém [capital of Pará])
  • Rare cases and sporadic foci of transmission in rural and forested areas in the states of Espírito Santo, Goiás, Minas Gerais, Mato Grosso do Sul, Piauí, Rio de Janeiro, São Paolo, and Tocantins
  • No malaria transmission in the cities of Brasília (the capital), Rio de Janeiro, or São Paolo
  • No malaria transmission at Iguaçu Falls
  
  • Chloroquine
  • P. vivax (90%)
  • P. falciparum (10%)
  • Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
  • Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"] ["P. falciparum", "P. vivax"] 1 3 risk area statement(s); 2 no-transmission exclusion(s) 2026-06-03T22:10:28Z

Links from other tables